Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open-Label, Maximal-Use Systemic Exposure Study

Guidelines of care for the management of atopic dermatitis

(2014) Robert Sidbury et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Guidelines of care for the management of atopic dermatitis

(2014) Lawrence F. Eichenfield et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Topical Calcineurin Inhibitors for Atopic Dermatitis: Review and Treatment Recommendations

(2013) Warner W. Carr   PEDIATRIC DRUGS

Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center

(2012) Yvonne R. Freund et al.   FEBS LETTERS

Calcineurin Inhibitors in Pediatric Atopic Dermatitis

(2010) Manjunatha Kalavala et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Discovery and structure–activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis

(2009) Tsutomu Akama et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Atopic Dermatitis

(2008) Thomas Bieber   NEW ENGLAND JOURNAL OF MEDICINE